TSHA FY 2020 Earnings — Taysha Gene Therapies, Inc. Revenue & Financial Results | Market Cap Arena

TSHATaysha Gene Therapies, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9,000

Operating Income

-$43M

Net Income

-$43M

EPS (Diluted)

$-3.40

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$40M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$259M

Total Liabilities

$8M

Stockholders' Equity

$251M

Cash & Equivalents

$251M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9,000	$0	—
Operating Income	-$43M	-$1M	-3756.7%
Net Income	-$43M	-$1M	-3756.5%